Oncology Solutions

One in seven men will be diagnosed with prostate cancer,1 with 1.2 million new cases in 2018.2 According to the American Cancer Society the overall 5-year survival rate is 99 percent for all stages of prostate cancer, however when diagnosed at stage IVB, the 5-year survival rate drops significantly to 29 percent.3

The Patient Journey

  • Early Detection

    SIGNA™ Artist - 70cm

    Now the potential for MR is even more astonish...
  • Diagnosis

    SIGNA™ Architect – 70 cm

    Now the potential for MR is even more astonishing with the SIGNA™ Architect, a state-of-the-art imaging solution that combines the advancements in MR technology with GE He...
  • Staging

    Computed Tomography

    저선량에서 더 높은 생산성과 효율성을 제공하는 고품질의 환자 치료의 중요성이 점점 높아지고 있습니다.  따라서 GE는 이러한 의료진의 요구에 부응할 수 있는 CT 시스템 개발에 최선을 다하고 있습니다. 
    의료진은 GE Healthcare 의 CT 제품군 중에서 정확한 영상화 요구에...
  • Treatment Planning
  • Therapy and Monitoring

    SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...
  • Follow up

    LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future. Choose from a wide array of advanced imagi...

The latest in Oncology

1. Prostate Cancer Risk Factors [Internet]. WebMD. 2018 [cited 5 November 2018]. Available from:
2. Prostate cancer statistics [Internet]. World Cancer Research Fund. 2018 [cited 5 November 2018]. Available from:
3. Survival Rates for Prostate Cancer [Internet]. 2018 [cited 5 November 2018]. Available from: Patel AR, Klein EA.